Coherus Oncology Inc (CHRS)

10:21 AM

What technical patterns form on Coherus Oncology Inc. (8C5) stock chartsMarket Sentiment Review & Weekly Return Optimization Plans - newser.com

10:21 AM

Oct 10, 2025

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga

Oct 10, 2025

Oct 09, 2025

How strong dollar benefits Coherus Oncology Inc. (8C5) stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com

Oct 09, 2025

Oct 09, 2025

Why Coherus Oncology Inc. (8C5) stock is trending on social mediaJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Published on: 2025-10-06 04:13:27 - newser.com

Oct 06, 2025

Oct 05, 2025

How Coherus Oncology Inc. (8C5) stock reacts to monetary easingJuly 2025 Review & Low Drawdown Trading Strategies - newser.com

Oct 05, 2025

Oct 05, 2025

Published on: 2025-10-05 03:27:37 - newser.com

Oct 05, 2025

Oct 03, 2025

Coherus Oncology, Inc. (NASDAQ:CHRS) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Oct 03, 2025

Oct 03, 2025

Coherus Oncology Announces Upcoming Presentation of CHS-114 Data at SITC 2025 Annual Meeting - Quiver Quantitative

Oct 03, 2025

Oct 03, 2025

Coherus Oncology Announces Poster Presentation at the 40th - GlobeNewswire

Oct 03, 2025

Oct 03, 2025

Selective intratumoral Treg depletion — Coherus Oncology's CHS-114 at SITC Nov 8; Webinar Oct 22 - Stock Titan

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 06:30:25 - newser.com

Oct 03, 2025

Oct 03, 2025

Will Coherus BioSciences Inc. outperform the marketMarket Risk Analysis & Low Risk High Reward Trade Ideas - newser.com

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 05:08:55 - newser.com

Oct 03, 2025

Oct 03, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Oct 03, 2025

Oct 01, 2025

Coherus BioSciences at UBS Virtual Oncology Day: Strategic Pipeline Focus By Investing.com - Investing.com Canada

Oct 01, 2025

Oct 01, 2025

Coherus Oncology: Five Readouts Or More Possible In 2026 - Seeking Alpha

Oct 01, 2025

Oct 01, 2025

Published on: 2025-10-01 05:00:35 - newser.com

Oct 01, 2025

Sep 29, 2025

What dividend safety rating applies to Coherus Oncology Inc. (8C5) stockMarket Risk Summary & Weekly Momentum Stock Picks - newser.com

Sep 29, 2025

Sep 28, 2025

What analysts say about Coherus Oncology Inc 8C5 stockStock Screening Results & Free Gain Edge With Data - earlytimes.in

Sep 28, 2025

Sep 26, 2025

Coherus Oncology Inc 8C5 Stock Analysis and ForecastEconomic Indicators Overview & Small Budget Wealth Tips - Early Times

Sep 26, 2025

Sep 25, 2025

Strs Ohio Acquires Shares of 324,000 Coherus Oncology, Inc. $CHRS - MarketBeat

Sep 25, 2025

Sep 22, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Passes Above 200 Day Moving AverageHere's Why - MarketBeat

Sep 22, 2025

Sep 22, 2025

3 Promising Penny Stocks With Market Caps At Least $100M - simplywall.st

Sep 22, 2025

Sep 19, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Sep 19, 2025

Sep 17, 2025

Coherus Oncology Inc (NASDAQ: CHRS) Rises 7.09% In Recent Trading, What’s Next? - stocksregister.com

Sep 17, 2025

Sep 11, 2025

Coherus Oncology, Inc. $CHRS Shares Sold by State of Wyoming - Defense World

Sep 11, 2025

Sep 10, 2025

Coherus BioSciences at H.C. Wainwright: Strategic Shift to Immuno-Oncology - Investing.com

Sep 10, 2025

Sep 10, 2025

Coherus BioSciences at H.C. Wainwright: Strategic Shift to Immuno-Oncology By Investing.com - Investing.com Canada

Sep 10, 2025

Sep 09, 2025

Maxim Group Upgrades Coherus Oncology (NASDAQ:CHRS) to "Buy" - MarketBeat

Sep 09, 2025

Sep 09, 2025

Coherus BioSciences at Baird Conference: Oncology Focus Amid Asset Sales - Investing.com

Sep 09, 2025

Sep 09, 2025

Coherus Biosciences Regains Nasdaq Compliance - The Globe and Mail

Sep 09, 2025

Sep 08, 2025

Coherus Oncology regains Nasdaq compliance after meeting minimum bid price - Investing.com

Sep 08, 2025

Sep 06, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat

Sep 06, 2025

Sep 06, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Rating Upgraded by Maxim Group - Defense World

Sep 06, 2025

Sep 05, 2025

Maxim Group Maintains Coherus Oncology(CHRS.US) With Buy Rating, Maintains Target Price $4 - 富途牛牛

Sep 05, 2025

Sep 04, 2025

Maxim Group upgrades Coherus Biosciences stock to Buy on oncology pivot By Investing.com - Investing.com South Africa

Sep 04, 2025

Sep 04, 2025

Maxim Group upgrades Coherus Biosciences stock to Buy on oncology pivot - Investing.com Canada

Sep 04, 2025

Sep 04, 2025

This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga

Sep 04, 2025

Sep 04, 2025

Coherus Oncology (CHRS) Receives Upgrade from Maxim Group | CHRS Stock News - GuruFocus

Sep 04, 2025

Sep 04, 2025

Maxim Group Upgrades Coherus Oncology to Buy, Sets PT at $4 - AInvest

Sep 04, 2025

Sep 03, 2025

RSI Reset May Fuel Rebound in Coherus BioSciences Inc.July 2025 Sector Moves & Technical Pattern Recognition Alerts - beatles.ru

Sep 03, 2025

Sep 03, 2025

Coherus Oncology to Participate in Upcoming Investor Conferences - The Manila Times

Sep 03, 2025